MRI Study Reveals Brain Differences in Patients with Migraine, Offering Hope for Better Diagnostics and Treatment
Posted on April 18 2024,

A recent study published in the journal Neurology has found interesting observations on the brain structure of people with migraine. The study compared MRI scans of 296 migraine patients to 155 healthy controls, analyzing cortical surface area, thickness, and volume.
The researchers found that migraine patients, especially those with chronic migraine, had reduced cortical surface area in the left anterior insula, a region involved in pain processing. They also discovered increased surface area in the right caudal anterior cingulate cortex (ACC) in chronic migraine, which correlated with monthly headache frequency. Furthermore, migraine without aura was associated with greater right caudal ACC surface area compared to controls.
No significant differences in cortical thickness or volume were found between migraine and control groups.
The study's findings have important implications for people with migraine. The distinct brain signatures observed in different migraine subtypes suggest that personalized diagnostics and therapies may be possible in the future.
The association between medication overuse/adaptation headache and brain structure changes also highlights the need for effective preventive treatments.
Finally, this is also further evidence that migraine is not “just in your head” as some therapy people we recently talked about like to claim. It is not fear-based, but real, anatomical, and functional changes occurring in the nervous system, including the brain.
Mon, Aug 04, 25
Evidence-Based Guide to Migraine Nutraceuticals and Herbal Options
Evidence-based guide to natural migraine treatments including riboflavin, magnesium, ginger, and CoQ10. Compare effectiveness, dosing, and safety of 15+ nutraceuticals and herbal remedies for migraine prevention and acute treatment with...
Read MoreMon, Jul 28, 25
Status Migrainosus Guide: A migraine attack lasting 72 hours or more
Status migrainosus is a severe migraine complication lasting over 72 hours requiring emergency treatment. Learn evidence-based management strategies, IV therapy protocols, diagnostic criteria, and prognosis from this comprehensive clinical guide...
Read MoreFri, Jul 25, 25
Understanding Cutaneous Allodynia in Migraine
Learn about skin hypersensitivity affecting 63% of migraine patients, validated assessment tools, suicide risks, and how allodynia predicts treatment response. Evidence-based insights from major population studies including AMPP and MAST...
Read More